|
GB8500209D0
(en)
|
1985-01-04 |
1985-02-13 |
Ceskoslovenska Akademie Ved |
Synthetic polymeric drugs
|
|
SE8702550D0
(sv)
|
1987-06-18 |
1987-06-18 |
Anders Grubb |
Cysteinproteashemmare
|
|
US5166172A
(en)
|
1988-09-01 |
1992-11-24 |
Takeda Chemical Industries, Ltd. |
Fumagillol derivatives and pharmaceutical compositions thereof
|
|
US4997878A
(en)
|
1988-12-29 |
1991-03-05 |
Exxon Research And Engineering Company |
Hydrophobically associating polymers containing dimethyl acrylamide functionality
|
|
US5258453A
(en)
|
1992-01-21 |
1993-11-02 |
University Of Utah |
Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
|
|
GB9320781D0
(en)
|
1993-10-08 |
1993-12-01 |
Erba Carlo Spa |
Polymer-bound camptothecin derivatives
|
|
US20030220233A1
(en)
|
1994-01-24 |
2003-11-27 |
Neorx Corporation |
Radiolabeled annexins
|
|
TW409058B
(en)
|
1996-06-06 |
2000-10-21 |
Daiichi Seiyaku Co |
Method for preparation of a drug complex
|
|
TW527183B
(en)
|
1996-06-06 |
2003-04-11 |
Daiichi Seiyaku Co |
Drug complex
|
|
US6759509B1
(en)
|
1996-11-05 |
2004-07-06 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
WO1999011272A1
(en)
|
1997-09-02 |
1999-03-11 |
Johns Hopkins University School Of Medicine |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
US6306819B1
(en)
|
1997-10-31 |
2001-10-23 |
Massachusetts Institute Of Technology |
Method for regulating size of vascularized normal tissue
|
|
KR100357542B1
(ko)
|
1998-05-15 |
2002-10-18 |
주식회사종근당 |
푸마질롤 유도체 및 그 제조방법
|
|
HK1040052B
(zh)
|
1998-05-22 |
2006-09-15 |
第一制药株式会社 |
药物复合物
|
|
US6464850B1
(en)
|
1998-07-31 |
2002-10-15 |
Biowhittaker Molecular Applications, Inc. |
Method for producing hydrophilic monomers and uses thereof
|
|
ID29943A
(id)
|
1998-10-30 |
2001-10-25 |
Daiichi Seiyaku Co |
Senyawa dds dan metode pengukurannya
|
|
EP1222217B1
(en)
|
1999-09-08 |
2005-06-15 |
Polytherics Limited |
Uniform molecular weight polymers
|
|
US6811788B2
(en)
|
2000-01-19 |
2004-11-02 |
Baofa Yu |
Combinations and methods for treating neoplasms
|
|
US20070161570A1
(en)
|
2000-11-01 |
2007-07-12 |
Praecis Pharmaceuticals, Inc. |
Methionine aminopeptidase-2 inhibitors and methods of use thereof
|
|
US6548477B1
(en)
|
2000-11-01 |
2003-04-15 |
Praecis Pharmaceuticals Inc. |
Therapeutic agents and methods of use thereof for the modulation of angiogenesis
|
|
EP1243276A1
(en)
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
EP1436286B1
(en)
|
2001-09-27 |
2009-08-19 |
Equispharm Co., Ltd. |
Fumagillol derivatives and preparing method thereof
|
|
WO2003070173A2
(en)
|
2002-02-15 |
2003-08-28 |
Sympore Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
|
AU2003230852B2
(en)
|
2002-04-11 |
2008-07-10 |
Children's Medical Center Corporation |
TNP-470 polymer conjugates and use thereof
|
|
US20040001801A1
(en)
|
2002-05-23 |
2004-01-01 |
Corvas International, Inc. |
Conjugates activated by cell surface proteases and therapeutic uses thereof
|
|
US20040116348A1
(en)
|
2002-09-23 |
2004-06-17 |
Ying Chau |
Polymer-linker-drug conjugates for targeted drug delivery
|
|
US20040228831A1
(en)
|
2003-05-15 |
2004-11-18 |
Belinka Benjamin A. |
Polymeric conjugates for tissue activated drug delivery
|
|
CN102321584B
(zh)
|
2003-12-31 |
2014-01-08 |
宾夕法尼亚州研究基金会 |
预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法
|
|
US20070287680A1
(en)
|
2004-05-10 |
2007-12-13 |
University Of Utah Research Foundation |
Combined Active and Passive Targeting of Biologically Active Agents
|
|
US7214664B2
(en)
|
2004-12-03 |
2007-05-08 |
The Curators Of The University Of Missouri |
Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
|
|
WO2006084054A2
(en)
|
2005-02-02 |
2006-08-10 |
Children's Medical Center Corporation |
Method of treating angiogenic diseases
|
|
US7629315B2
(en)
|
2005-03-09 |
2009-12-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Compositions for blocking the inhibitory effect of human CRP on human leptin
|
|
WO2006124711A1
(en)
|
2005-05-16 |
2006-11-23 |
The Board Of Trustees Of The University Of Illinois |
Composition and method for providing localized delivery of a therapeutic agent
|
|
EP2170402B1
(en)
|
2007-06-26 |
2015-03-25 |
Children's Medical Center Corporation |
Metap-2 inhibitor polymersomes for therapeutic administration
|
|
WO2009036108A1
(en)
|
2007-09-13 |
2009-03-19 |
Children's Medical Center Corporation |
Methods and compositions for inhibiting vascular leakage
|
|
US20090104210A1
(en)
|
2007-10-17 |
2009-04-23 |
Tota Michael R |
Peptide compounds for treating obesity and insulin resistance
|
|
EP2217283A2
(en)
|
2007-11-28 |
2010-08-18 |
Mersana Therapeutics, Inc. |
Biocompatible biodegradable fumagillin analog conjugates
|
|
WO2009087664A1
(en)
*
|
2007-12-04 |
2009-07-16 |
Cadila Healthcare Limited |
Process for preparing chemically and chirally pure solifenacin base and its salts
|
|
WO2009094155A1
(en)
*
|
2008-01-22 |
2009-07-30 |
Thar Pharmaceuticals |
In vivo studies of crystalline forms of meloxicam
|
|
WO2009141826A2
(en)
|
2008-05-22 |
2009-11-26 |
Ramot At Tel Aviv University Ltd. |
Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
|
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
|
WO2010065877A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Methods of treating an overweight or obese subject
|
|
US8642650B2
(en)
|
2008-12-04 |
2014-02-04 |
Zafgen, Inc. |
Methods of treating an overweight or obese subject
|
|
TWI373345B
(en)
|
2009-02-19 |
2012-10-01 |
Academia Sinica |
Breast cancer-targeting peptides and use thereof
|
|
EP2493497A4
(en)
|
2009-11-01 |
2013-07-24 |
Brigham & Womens Hospital |
NOTCH INHIBITION IN THE TREATMENT AND PROPHYLAXIS OF ADIPOSITAS AND METABOLISM SYNDROME
|
|
WO2011127304A2
(en)
|
2010-04-07 |
2011-10-13 |
Zafgen Corporation |
Methods of treating an overweight subject
|
|
DK2576638T3
(da)
|
2010-05-25 |
2021-03-15 |
Syndevrx Inc |
Polymerkonjugerede metap2-inhibitorer og terapeutiske fremgangsmåder til anvendelse deraf
|
|
US20110294952A1
(en)
|
2010-05-25 |
2011-12-01 |
SynDevRX |
Optimized Drug Conjugates
|
|
US9895449B2
(en)
|
2010-05-25 |
2018-02-20 |
Syndevrx, Inc. |
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
EP2683706B1
(en)
|
2011-03-08 |
2018-02-21 |
Zafgen, Inc. |
Oxaspiro [2.5]octane derivatives and analogs
|
|
BR112014027981A2
(pt)
*
|
2012-05-09 |
2017-06-27 |
Zafgen Inc |
compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
|
|
CN105431426A
(zh)
*
|
2013-04-10 |
2016-03-23 |
新德发制药有限公司 |
Metap2抑制剂和治疗肥胖症的方法
|
|
US9969722B2
(en)
*
|
2015-12-10 |
2018-05-15 |
Syndevrx, Inc. |
Fumagillol derivatives and polymorphs thereof
|
|
CN108697807B
(zh)
|
2016-01-11 |
2021-11-26 |
辛德弗雷克斯公司 |
代谢功能障碍引起的肿瘤的治疗
|